Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 159 results.
User Information
Export Records
  1. 1.   Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy
  2. Rosa, Lorena; Cook, Paz; Pfeiffer, Ruth M; Kemp,Troy; Hildesheim, Allan; Pehlivanoglu, Burcin; Adsay, Volkan; Bellolio, Enrique; Araya, Juan Carlos; Pinto,Ligia; Ferreccio, Catterina; Aguayo, Gloria; Viñuela, Eduardo; Koshiol, Jill
  3. International Journal of Cancer. 2024, Oct 31;
  1. 2.   SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities
  2. Liu,Yonglan; Zhang,Wengang; Jang,Hyunbum; Nussinov,Ruth
  3. Cellular and Molecular Life Sciences : CMLS. 2023, Dec 12; 81(1): 5.
  1. 3.   Scaffolding viral protein NC nucleates phase separation of the HIV-1 biomolecular condensate
  2. Monette, Anne; Niu, Meijuan; Nijhoff Asser, Maya; Gorelick,Robert; Mouland, Andrew J
  3. Cell Reports. 2022, Aug 23; 40(8): 111251.
  1. 4.   Complex Tumor Spheroids, a Tissue-Mimicking Tumor Model, for Drug Discovery and Precision Medicine
  2. Kaur, Gurmeet; Evans, David M.; Teicher, Beverly A.; Coussens,Nathan
  3. SLAS Discovery. 2021, Nov 12;
  1. 5.   Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
  2. Hikichi,Yuta; Van Duyne, Rachel; Pham,Phuong; Groebner,Jenn; Wiegand,Ann; Mellors, John W; Kearney,Mary; Freed,Eric
  3. mBio. 2021, Jan; 12(1):
  1. 6.   LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples
  2. Masood, M Athar; Veenstra, Timothy D
  3. Basic & clinical pharmacology & toxicology. 2020, Nov 01;
  1. 7.   The indenoisoquinoline LMP517: a novel antitumor agent targeting both TOP1 and TOP2
  2. Marzi, Laetitia; Sun, Yilun; Huang, Shar-Yin N; James,Amy; Difilippantonio,Simone; Pommier, Yves
  3. Molecular cancer therapeutics. 2020, AUG; 19(8): 1589-1597.
  1. 8.   PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
  2. Bavli, Yaelle; Chen, Bing-Mae; Roffler, Steve R; Dobrovolskaia,Marina; Elnekave, Eldad; Ash, Shifra; Barenholz, Yechezkel; Turjeman, Keren
  3. Molecules (Basel, Switzerland). 2020, Jan 28; 25(3): pii: molecules25030558.
  1. 9.   Autoinhibition can identify rare driver mutations and advise pharmacology
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020, Jan; 34(1): 16-29.
  1. 10.   Half blind superiority tests for clinical trials of anti-infective drugs
  2. Follmann, Dean; Brittain, Erica; Lumbard, Keith
  3. Statistics in Medicine. 2019, Jan 15; 38(1): 31-43.
  1. 11.   Design and biological activity of novel stealth polymeric lipid nanoparticles for enhanced delivery of hydrophobic photodynamic therapy drugs
  2. Viard, Mathias; Reichard, Henry; Shapiro, Bruce; Durrani, Farukh A; Marko, Aimee J; Watson, R Michelle; Pandey, Ravindra K; Puri, Anu
  3. Nanomedicine : nanotechnology, biology, and medicine. 2018, Oct; 14(7): 2295-2305.
  1. 12.   Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery
  2. Tian, Xiang Rong; Tang, Hai Feng; Tian, Xiao Lin; Hu, Jia Jun; Huang, Li Li; Gustafson, Kirk
  3. Future medicinal chemistry. 2018, Jun; 10(12): 1497-1514.
  1. 13.   Local and global anatomy of antibody-protein antigen recognition
  2. Wang, Meryl; Zhu, David; Zhu, Jianwei; Nussinov, Ruth; Ma, Buyong
  3. Journal of Molecular Recognition: JMR. 2018, May; 31(5): e2693.
  1. 14.   Equivalence of complex drug products: advances in and challenges for current regulatory frameworks.
  2. Hussaarts, Leonie; Mühlebach, Stefan; Shah, Vinod P; McNeil, Scott; Borchard, Gerrit; Flühmann, Beat; Weinstein, Vera; Neervannan, Sesha; Griffiths, Elwyn; Jiang, Wenlei; Wolff-Holz, Elena; Crommelin, Daan J A; de Vlieger, Jon S B
  3. Annals of the New York Academy of Sciences. 2017, Nov; 1407(1, SI): 39-49.
  1. 15.   Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1)
  2. Bermingham, Alun; Price, Edmund; Marchand, Christophe; Chergui, Adel; Naumova, Alena; Whitson, Emily L; Haugh Krumpe, Lauren; Goncharova, Katya; Evans, Jason; McKee, Tawnya; Henrich, Curtis; Pommier, Yves; O'Keefe, Barry
  3. SLAS discovery. 2017, Oct; 22(9): 1093-1105.
  1. 16.   LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples
  2. Athar Masood, M; Veenstra, Timothy D
  3. Basic & Clinical Pharmacology & Toxicology. 2017, Aug 26;
  1. 17.   Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS)
  2. Legrice, Stuart; Sztuba-Solinska, Joanna; Maccioni, Elias; Purzycka, Katarzyna J; Parolin, Cristina; Tramontano, Enzo
  3. Antiviral research. 2017, Mar; 139: 13-17.
  1. 18.   Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
  2. Devkota, L.; Lin, C. M.; Strecker, T. E.; Wang, Y.; Tidmore, J. K.; Chen, Z.; Guddneppanavar, R.; Jelinek, C. J.; Lopez, R.; Liu, L.; Hamel, E.; Mason, R. P.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.
  3. Bioorganic & Medicinal Chemistry. 2016, 1-Mar; 24(5): 938-56.
  1. 19.   Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
  2. Basudhar, Debashree; Miranda, Katrina M.; Wink, David; Ridnour, Lisa
  3. REDOX-ACTIVE THERAPEUTICS. 2016; : 377-403.
  1. 20.   Diazeniumdiolated carbamates: A novel class of nitric oxide donors
  2. Nandurdikar, R. S.; Maciag, A. E.; Cao, Z.; Keefer, L. K.; Saavedra, J. E.
  3. Bioorganic & Medicinal Chemistry. 2012, Mar; 20(6): 2025-2029.
  1. 21.   Synergistic Interaction of the Triple Combination of Amphotericin B, Ciprofloxacin, and Polymorphonuclear Neutrophils against Aspergillus fumigatus
  2. Stergiopoulou, T.; Meletiadis, J.; Sein, T.; Papaioannidou, P.; Walsh, T. J.; Roilides, E.
  3. Antimicrobial Agents and Chemotherapy. 2011, Dec; 55(12): 5923-5929.
  1. 22.   Design and Synthesis of 2-Heterocyclyl-3-arylthio-1H-indoles as Potent Tubulin Polymerization and Cell Growth Inhibitors with Improved Metabolic Stability
  2. La Regina, G.; Bai, R.; Rensen, W.; Coluccia, A.; Piscitelli, F.; Gatti, V.; Bolognesi, A.; Lavecchia, A.; Granata, I.; Porta, A.; Maresca, B.; Soriani, A.; Iannitto, M. L.; Mariani, M.; Santoni, A.; Brancale, A.; Ferlini, C.; Dondio, G.; Varasi, M.; Mercurio, C.; Hamel, E.; Lavia, P.; Novellino, E.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2011, Dec; 54(24): 8394-8406.
  1. 23.   Ionic Liquids: Neoteric Solvents for Nucleoside Chemistry
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Current Organic Synthesis. 2011, Dec; 8(6): 777-786.
  1. 24.   Application of silver N-heterocyclic carbene complexes in O-glycosidation reactions
  2. Talisman, I. J.; Kumar, V.; Deschamps, J. R.; Frisch, M.; Malhotra, S. V.
  3. Carbohydrate Research. 2011, Nov; 346(15): 2337-2341.
  1. 25.   Synthetic and Application Perspectives of Azapodophyllotoxins: Alternative Scaffolds of Podophyllotoxin
  2. Kumar, A.; Kumar, V.; Alegria, A. E.; Malhotra, S. V.
  3. Current Medicinal Chemistry. 2011, Sep; 18(25): 3853-3870.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel